Joerg Gruber - Pathfinder Cell Founder and Chairman

PFND Stock  USD 0.0001  0.00  0.00%   

Chairman

Mr. Joerg Gruber is a Chairman of the Board of Pathfinder Cell Therapy, Inc., since September 2011 and as a director since April 2007. Mr. Gruber cofounded Clubb Capital Limited, a Londonbased corporate finance and VC firm with a principal focus on healthcare, in 1995 and was its Chairman since 1999. Prior to his career in VC, Mr. Gruber spent 14 years in banking and investment banking at UBS, Goldman Sachs and Lehman Brothers. Mr. Gruber cofounded Pathfinder, LLC with Dr. Franklin. Mr. Gruber has served as Chairman of Pathfinder, LLC since 2008 and as Chairman of Tarix Pharmaceuticals since 2007. Mr. Gruber is Chairman of Tarix Orphan LLC, a company focused on the development of peptides to treat muscular dystrophy and Marfan syndrome and is also a director of AvidBiologics Inc., a privatelyheld biopharmaceutical company specializing in the development of oncology products. since 2011.
Age 62
Tenure 13 years
Phone617-245-0289
Webhttps://www.pathfindercelltherapy.com

Pathfinder Cell Management Efficiency

The company has return on total asset (ROA) of (8.8876) % which means that it has lost $8.8876 on every $100 spent on assets. This is way below average. Pathfinder Cell's management efficiency ratios could be used to measure how well Pathfinder Cell manages its routine affairs as well as how well it operates its assets and liabilities.
The company currently holds 5.41 M in liabilities. Debt can assist Pathfinder Cell until it has trouble settling it off, either with new capital or with free cash flow. So, Pathfinder Cell's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Pathfinder Cell Therapy sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Pathfinder to invest in growth at high rates of return. When we think about Pathfinder Cell's use of debt, we should always consider it together with cash and equity.

Similar Executives

Found 2 records

CHAIRMAN Age

John ZimmerLYFT Inc
40
Logan GreenLYFT Inc
40
Pathfinder Cell Therapy, Inc., a development stage regenerative medicine company, focuses on developing novel cell-derived and related therapies for the treatment of various diseases and medical conditions characterized by organ-specific cell damage. The company was founded in 2008 and is headquartered in Cambridge, Massachusetts. PATHFINDER CELL operates under Biotechnology classification in the United States and is traded on PNK Exchange. It employs 1 people. Pathfinder Cell Therapy [PFND] is a Pink Sheet which is traded between brokers as part of OTC trading.

Management Performance

Pathfinder Cell Therapy Leadership Team

Elected by the shareholders, the Pathfinder Cell's board of directors comprises two types of representatives: Pathfinder Cell inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Pathfinder. The board's role is to monitor Pathfinder Cell's management team and ensure that shareholders' interests are well served. Pathfinder Cell's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Pathfinder Cell's outside directors are responsible for providing unbiased perspectives on the board's policies.
John Benson, CFO and Treasurer
Richard Franklin, President CEO, Secretary, Director
Zen Chu, Independent Director
John Alam, Independent Director
Brock Reeve, Independent Director
Joerg Gruber, Founder and Chairman
John Brooks, Independent Director

Pathfinder Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Pathfinder Cell a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Pathfinder Cell Therapy using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Pathfinder Cell Therapy. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors.
You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Complementary Tools for Pathfinder Pink Sheet analysis

When running Pathfinder Cell's price analysis, check to measure Pathfinder Cell's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pathfinder Cell is operating at the current time. Most of Pathfinder Cell's value examination focuses on studying past and present price action to predict the probability of Pathfinder Cell's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pathfinder Cell's price. Additionally, you may evaluate how the addition of Pathfinder Cell to your portfolios can decrease your overall portfolio volatility.
Transaction History
View history of all your transactions and understand their impact on performance
Stocks Directory
Find actively traded stocks across global markets
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
CEOs Directory
Screen CEOs from public companies around the world
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Fundamental Analysis
View fundamental data based on most recent published financial statements
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Please note, there is a significant difference between Pathfinder Cell's value and its price as these two are different measures arrived at by different means. Investors typically determine if Pathfinder Cell is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Pathfinder Cell's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.